Skip to main content

MetroCream

Generic: metronidazole

Verified·Apr 23, 2026
Manufacturer
Galderma
NDC
0299-3836
RxCUI
211666
Route
TOPICAL
ICD-10 indication
L71.9

Affordability Check

How much will you actually pay for MetroCream?

In 30 seconds, see every legitimate way to afford MetroCream — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About MetroCream

What is this medication? MetroCream is a topical prescription medication containing metronidazole that is specifically used to treat the inflammatory symptoms of rosacea. This condition often causes persistent redness, as well as the development of small, red, pus-filled bumps or papules on the face. The cream is applied directly to the skin to help manage these visible flare-ups and improve the overall texture and appearance of the affected areas.

Although the exact mechanism of action is not fully understood, the medication works through its antimicrobial and anti-inflammatory properties to reduce skin irritation. It belongs to the nitroimidazole class of antibiotics and is effective at decreasing the number of lesions caused by rosacea. Most patients use it as part of a long-term treatment plan under the guidance of a physician to keep their symptoms under control and minimize future breakouts.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for MetroCream. Official source: DailyMed (NLM) · Label effective Jun 26, 2018

Indications and usage
INDICATIONS AND USAGE: METROCREAM ® (metronidazole topical cream) Topical Cream is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.
Dosage and administration
DOSAGE AND ADMINISTRATION: Apply and rub in a thin layer of METROCREAM ® (metronidazole topical cream) Topical Cream twice daily, morning and evening, to entire affected areas after washing. Areas to be treated should be washed with a mild cleanser before application. Patients may use cosmetics after application of METROCREAM ® (metronidazole topical cream) Topical Cream.
Contraindications
CONTRAINDICATIONS: METROCREAM ® (metronidazole topical cream) Topical Cream is contraindicated in individuals with a history of hypersensitivity to metronidazole, or other ingredients of the formulation.
Adverse reactions
ADVERSE REACTIONS: In controlled clinical trials, the total incidence of adverse reactions associated with the use of METROCREAM ® Topical Cream was approximately 10%. Skin discomfort (burning and stinging) was the most frequently reported event followed by erythema, skin irritation, pruritus and worsening of rosacea. All individual events occurred in less than 3% of patients. The following additional adverse experiences have been reported with the topical use of metronidazole: dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How MetroCream appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

0%

2 of 5,509 plans

Most common tier

Tier 1

On 100% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)1
100%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 1 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.